13F-HR filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 112 holding rows worth $5,757,958,145.
- Accession
- 0001012975-24-000218
- Filer
- CIK 1224962
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 112 entries on the cover page, a total value of $5,757,958,145 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,757,958,145 with VALUE read as dollars as filed, 13F file number 028-10438. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 10,794,876 | $456,299,409 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 28,057,456 | $330,516,832 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 19,272,991 | $285,625,572 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 3,933,556 | $273,578,820 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 2,783,454 | $209,009,561 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 2,699,345 | $179,371,475 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 4,256,104 | $148,793,396 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 6,825,395 | $145,517,421 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 3,268,579 | $141,627,528 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 1,932,759 | $132,026,767 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 3,074,542 | $131,590,398 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 1,429,563 | $124,586,415 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 429,953 | $114,814,649 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 2,262,462 | $111,358,380 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 804,409 | $110,944,089 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,556,679 | $96,974,834 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,963,212 | $95,741,380 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,725,047 | $94,342,820 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 6,906,646 | $91,996,524 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 6,485,420 | $91,249,859 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,105,341 | $88,206,212 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 994,098 | $81,516,036 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 5,753,798 | $80,553,172 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 12,757,562 | $79,352,035 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 3,448,004 | $76,959,449 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 1,055,355 | $73,030,566 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 757,225 | $69,255,799 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,476,203 | $69,101,062 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 11,331,103 | $68,723,711 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 525,683 | $68,054,921 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,657,099 | $64,035,803 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 3,761,576 | $60,523,758 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 939,866 | $58,516,057 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,304,105 | $57,250,210 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 2,668,978 | $56,475,574 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 8,005,000 | $54,434,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,236,603 | $51,046,972 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 2,362,279 | $51,025,226 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 821,589 | $50,133,361 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,801,068 | $48,520,772 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 4,582,409 | $48,161,118 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,296,416 | $47,124,722 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,412,033 | $43,660,060 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 6,433,369 | $42,460,235 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,319,646 | $42,310,343 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 7,099,182 | $42,027,157 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 101,800 | $40,627,362 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 892,208 | $38,409,554 | dollars as filed | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 12,594,211 | $37,026,980 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,387,471 | $35,047,517 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 3,083,307 | $34,841,369 | dollars as filed | |
| LANDOS BIOPHARMA INC | 515069201 | COMMON | 1,486,991 | $31,940,566 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 3,324,468 | $30,252,659 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 2,304,954 | $30,079,650 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,716,660 | $29,286,220 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 994,323 | $28,765,764 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 245,205 | $28,443,780 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 8,593,586 | $28,101,026 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,330,745 | $27,630,153 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 3,007,858 | $21,506,185 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 1,410,438 | $20,733,439 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 618,885 | $19,946,664 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 106,500 | $19,393,650 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 300,000 | $18,678,000 | dollars as filed | put |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 339,012 | $17,028,573 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 998,888 | $16,931,152 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 299,000 | $16,726,060 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 5,402,964 | $14,804,121 | dollars as filed | |
| TACTILE SYSTEMS TECHNOLOGY I | 87357P100 | COMMON STOCK | 903,085 | $14,675,131 | dollars as filed | |
| ORCHESTRA BIOMED HOLDINGS IN | 68572M106 | COMMON STOCK | 2,545,881 | $13,416,793 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 1,553,929 | $12,540,207 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 589,646 | $12,187,983 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,074,807 | $11,306,970 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 1,223,472 | $10,986,779 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 669,159 | $10,974,208 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 210,659 | $10,410,768 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 288,221 | $10,145,379 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 867,319 | $8,864,000 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 750,000 | $7,432,500 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 415,000 | $7,411,900 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 480,483 | $6,515,349 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 883,333 | $5,935,998 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 500,000 | $5,930,000 | dollars as filed | |
| IMMUNITYBIO INC | 45256X103 | COM | 1,052,887 | $5,654,003 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 378,327 | $5,568,973 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 500,000 | $5,200,000 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 3,545,454 | $4,928,181 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 1,679,125 | $4,768,715 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 50,000 | $4,744,500 | dollars as filed | put |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 82,299 | $4,189,019 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 175,000 | $4,138,750 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 700,000 | $3,976,000 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 5,584,699 | $3,909,848 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 150,000 | $3,726,000 | dollars as filed | |
| TRINITY BIOTECH INVT LTD | 896438504 | SPONS ADR NEW | 1,800,000 | $3,672,000 | dollars as filed | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 555,066 | $3,607,873 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 500,000 | $3,400,000 | dollars as filed | call |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 623,315 | $3,390,834 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 700,000 | $3,346,000 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $3,231,000 | dollars as filed | call |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 600,000 | $2,952,000 | dollars as filed | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 100,000 | $2,924,000 | dollars as filed | call |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 3,265,359 | $2,273,343 | dollars as filed | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 2,126,893 | $1,093,648 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 48,200 | $1,028,106 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 300,000 | $852,000 | dollars as filed | |
| VBI VACCINES INC | 91822J202 | Foreign Stock | 1,261,710 | $757,026 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 116,754 | $624,634 | dollars as filed | |
| CAREMAX INC | 14171W202 | COM | 122,643 | $591,139 | dollars as filed | |
| REVOLUTION MEDICINES INC | 76155X118 | *W EXP 12/17/202 | 250,000 | $45,625 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $5,033 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 60,000 | $1,026 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-24-000218 | this filing | 2024-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-24-000315 | base | 2024-08-06 | acceptance time not in the bulk data set |